Florida

Showing 21-27 of 27 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema	Jaeb Center for Health Research	Adam Glassman	Improving Lives	01-September-2022 to 01-January-2026	$273.424,00
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D)	AdventHealth	Richard Pratley	Improving Lives	01-September-2023 to 20-May-2026	$110.840,00
Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression	University of Florida	Sarah Kim	Cures	01-June-2022 to 31-May-2026	$750.000,00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes	iTolerance, Inc.	Camillo Ricordi	Cures	01-June-2022 to 15-November-2026	$850.000,00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening	Jaeb Center for Health Research	Adam Glassman	Improving Lives	01-February-2021 to 31-August-2026	$750.000,00
JDRF T1D Coordinating Center	Jaeb Center for Health Research	Judy Sibayan	Transportfolio	01-August-2019 to 31-August-2027	$2.914.531,01
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D	University of Florida	Graciela Lorca	Cures	01-September-2019 to 31-August-2026	$355.941,78